ABSTRACT
We compared the gene expression profile of adult acute lymphoblastic leukemia (ALL) to normal hematopoietic and non-ALL samples using oligonucleotide arrays. Connective tissue growth factor (CTGF) was the highest over-expressed gene in B-cell ALL compared to the other groups, and displayed heterogeneous expression, suggesting it might have prognostic relevance. CTGF expression was examined by quantitative RT-PCR on 79 adult ALL specimens. CTGF expression levels were significantly increased in ALL cases with B-lineage (p=0.0001), unfavorable cytogenetics (p=0.0002), and blasts expressing CD34 (p<0.0001). In a multivariate proportional hazards model, higher CTGF expression levels corresponded to worsening of OS (hazard ratio=1.36, for each 10-fold increase in expression; p=0.019). Further studies are ongoing to confirm the prognostic value of CTGF expression in ALL and to investigate its role in normal and abnormal lymphocyte biology.
INTRODUCTION
Prognosis of adults with acute lymphoblastic leukemia (ALL) is poor, especially when contrasted with the impressive progress made in curing pediatric ALL. Even with increasingly intensive chemotherapy regimens, relapse rates remain high, and longterm survival is 40% [1] [2] [3] [4] [5] . Transplantation regimens can be curative, but it remains challenging to identify high-risk patients suitable for early transplantation. Age, cytogenetic abnormalities, WBC count, and time to achieve complete remission (CR) are risk factors in adult ALL [4] [5] [6] . New prognostic biomarkers may fine-tune risk assessment in adult ALL.
We compared gene expression profile of adult ALL to control samples, and found that For gene expression arrays 5 µg of total RNA were processed and hybridized onto HG-U133A arrays according to Affymetrix's GeneChip expression protocol (details at www.affymetrix.com). Gene expression data were normalized and extracted using the RMA method . This heterogeneous over-expression of CTGF in B-ALL, led us to suspect CTGF association with prognosis.
Q-RT-PCR levels of CTGF.
The median expression of CTGF in ALL specimens was For personal use only. on November 16, 2017. by guest www.bloodjournal.org From CTGF is located on chromosome band 6q23, and it is not expressed in normal leukocytes 13, 14 . We show uniformly low CTGF levels in normal PB and BM by microarrays and Q-RT-PCR. Thus, it seems unlikely other cellular components (i.e. other blood or marrow stromal cells) influenced CTGF values in leukemic samples.
In vivo studies suggest a role of CTGF in adhesion 15 , cell cycle control 16 , and proliferation 17 , and it has been linked to the TGF-ß 18 and Wnt 19, 20 pathways. CTGF is expressed in solid malignancies, but a role in neoplastic transformation is unclear [21] [22] [23] [24] .
Vorwerk et al. reported CTGF expression in malignant lymphoblasts in pediatric patients 14 , by qualitative RT-PCR. In contrast to our study, they did not find any difference in the expression of CTGF among patients who relapsed versus patients in continuous CR 25 . Differences in these studies may be technical, or due to the different population targeted.
In our study, CTGF expression level was an independent predictor of OS, suggesting it provides additional prognostic stratification in B-ALL patients. This finding and the role of CTGF in ALL biology will be clarified with validation studies in larger clinical trials and basic biological studies. 
VARIABLE

